MX2007013230A - Uso de una formulacion en aerosol de clobetasol para tratar psoriasis. - Google Patents

Uso de una formulacion en aerosol de clobetasol para tratar psoriasis.

Info

Publication number
MX2007013230A
MX2007013230A MX2007013230A MX2007013230A MX2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A MX 2007013230 A MX2007013230 A MX 2007013230A
Authority
MX
Mexico
Prior art keywords
spray formulation
treatment psoriasis
psoriasis
clobetasol
pharmaceutical composition
Prior art date
Application number
MX2007013230A
Other languages
English (en)
Inventor
Gordon J Dow
Daniel M Stewart
Original Assignee
Dow Pharmaceutical Sciences Y
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences Y filed Critical Dow Pharmaceutical Sciences Y
Publication of MX2007013230A publication Critical patent/MX2007013230A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Abstract

La actual invencion proporciona una composicion farmaceutica para tratar psoriasis, para ser rociada sobre la piel con psoriasis diariamente durante por lo menos 4 semanas, la composicion contiene una cantidad eficaz de propionato de clobetasol. La composicion farmaceutica preferida contiene propionato de clobetasol, alcohol etilico miristato de isopropilo y surfactante anionico.
MX2007013230A 2005-04-25 2006-04-20 Uso de una formulacion en aerosol de clobetasol para tratar psoriasis. MX2007013230A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67494605P 2005-04-25 2005-04-25
PCT/US2006/014903 WO2006115987A2 (en) 2005-04-25 2006-04-20 Use of a clobetasol spray formulation to treat psoriasis

Publications (1)

Publication Number Publication Date
MX2007013230A true MX2007013230A (es) 2008-04-17

Family

ID=37215257

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007013230A MX2007013230A (es) 2005-04-25 2006-04-20 Uso de una formulacion en aerosol de clobetasol para tratar psoriasis.

Country Status (18)

Country Link
US (2) US20060239929A1 (es)
EP (1) EP1885373B1 (es)
JP (1) JP2008539236A (es)
KR (2) KR20080047312A (es)
CN (1) CN101208096A (es)
AU (1) AU2006241285B2 (es)
BR (1) BRPI0608334A2 (es)
CA (1) CA2607434A1 (es)
DK (1) DK1885373T3 (es)
ES (1) ES2539634T3 (es)
HU (1) HUE025462T2 (es)
MX (1) MX2007013230A (es)
PL (1) PL1885373T3 (es)
PT (1) PT1885373E (es)
RU (1) RU2397769C2 (es)
SI (1) SI1885373T1 (es)
WO (1) WO2006115987A2 (es)
ZA (1) ZA200709327B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120142605A1 (en) * 2009-05-05 2012-06-07 Amgen Inc. Methods of treating psoriasis
EP2473161B1 (en) 2009-08-31 2017-05-17 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
US8992994B2 (en) 2010-10-21 2015-03-31 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
US9789123B2 (en) 2010-10-21 2017-10-17 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
ES2857602T3 (es) 2014-03-11 2021-09-29 Promius Pharma Llc Composiciones tópicas de corticosteroides
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2017037663A1 (en) 2015-09-02 2017-03-09 Cadila Healthcare Limited Topical compositions comprising corticosteroids
KR102399484B1 (ko) 2015-09-15 2022-05-17 주식회사 엘지생활건강 건선 치료제 전달을 위한 용해성 미세바늘 패치
KR102631435B1 (ko) 2016-06-10 2024-01-29 주식회사 엘지생활건강 타박상 치료제 전달을 위한 용해성 미세바늘 패치
US20210069214A1 (en) * 2019-09-06 2021-03-11 Encore Dermatology, Inc. Topical compositions comprising a corticosteroid for the treatment of psoriasis in pediatric patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972920A (en) * 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US5886038A (en) * 1998-03-24 1999-03-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US6579512B2 (en) * 2001-06-15 2003-06-17 Crutchfield, Iii Charles E. Topical steroid spray

Also Published As

Publication number Publication date
BRPI0608334A2 (pt) 2009-12-01
RU2007143420A (ru) 2009-06-10
KR20080047312A (ko) 2008-05-28
ZA200709327B (en) 2009-01-28
RU2397769C2 (ru) 2010-08-27
US20060239929A1 (en) 2006-10-26
JP2008539236A (ja) 2008-11-13
PT1885373E (pt) 2015-09-10
HUE025462T2 (en) 2016-02-29
EP1885373A2 (en) 2008-02-13
EP1885373A4 (en) 2010-08-18
CA2607434A1 (en) 2006-11-02
US20140148426A1 (en) 2014-05-29
PL1885373T3 (pl) 2015-12-31
SI1885373T1 (sl) 2016-03-31
EP1885373B1 (en) 2015-05-20
WO2006115987A8 (en) 2008-10-16
KR20110108426A (ko) 2011-10-05
WO2006115987A2 (en) 2006-11-02
ES2539634T3 (es) 2015-07-02
CN101208096A (zh) 2008-06-25
AU2006241285A1 (en) 2006-11-02
WO2006115987A3 (en) 2006-12-14
DK1885373T3 (en) 2015-08-10
AU2006241285B2 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
MX2007013230A (es) Uso de una formulacion en aerosol de clobetasol para tratar psoriasis.
WO2010001293A3 (en) Sprayable skin protectant formulation and method of use
WO2008010167A3 (en) Treatment articles capable of delivering intensive care and overall treatment simultaneously
HK1091151A1 (en) Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite
NZ539841A (en) Hydroxyethylamine derivatives for the treatment of alzheimer's disease
BRPI0113670B8 (pt) composição farmacêutica e método para tratar hipogonadismo
EP1673078A4 (en) BENZYL ETHER AND BENZYLAMINO BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
WO2007113851A3 (en) Novel compositions for hair disorders and process of preparation thereof
WO2007130113A3 (en) Parathyroid hormone analogues and methods of use
MX2009010675A (es) Formulaciones farmaceuticas de moleculas de la hormona liberadora de la hormona delcrecimiento humana.
MXPA04001231A (es) Composiciones topicas para aplicar y no enjuagar que contiene derivados seleccionados del acido pantotenico.
ATE366760T1 (de) Folienzusammensetzung zur lokalen anwendung und verwendung zur freisetzung von aktivstoffen
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
WO2007098591A3 (en) Topical nail formulation
WO2011059324A3 (en) Composition for topical application, uses thereof, applicator device and kit of parts
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
PL1771180T3 (pl) Kompozycja w postaci sprayu zawierająca kombinację propionianu klobetazolu i kalcytriolu, fazę alkoholową i fazę olejową
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
WO2019059511A3 (ko) 3,4-디-카페오일퀴닌산을 포함하는, 활성산소종, 자외선 또는 미세먼지에 대한 피부 보호용 화장료 조성물
WO2003103699A8 (en) USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS
DE602006005637D1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
AU2003229269A1 (en) Deposition method for endoprostheses provided for constantly administering medicaments
CY1116851T1 (el) Χρηση συνθεσης ψεκασματος κλομπεταζολης για την θεραπευτικη αγωγη της ψωριασης